2016年5月13日

Success Stories: NIW Petition Approved for Petitioner in Delaware in the Field of Biochemistry


Client’s Testimonial:
“I will certainly recommend your law firm to my friends.”

On February 8th, 2016, we received another EB-2 NIW (National Interest Waiver) approval for a Petitioner in the Field of Biochemistry (Approval Notice).

 
 
 
 
General Field: Biochemistry
Position at the Time of Case Filing: N/A
Country of Origin: India
Service Center: Texas Service Center (TSC)
State of Residence at the Time of Filing: Delaware
Approval Notice Date: February 8th, 2016
Processing Time: 1 month, 25 days


 
Case Summary:
This EB-2 NIW (National Interest Waiver) case involved a petitioner from India whose research is specialized in the field of biochemistry. Her work involves the study of neurological diseases and how the disruption of metabolic processes caused by mitochondrial malfunction is associated with those diseases.
Our client’s Ph.D. in Biochemistry and Neuroscience has laid the groundwork for an illustrious career in the field. In preparing the EB-2 NIW petition, we proved that her development of new treatments and preventative techniques directly contributes to our nation’s medical research community, which is constantly working towards improved therapies for neurological disease such as Alzheimer’s or Huntington’s. Additionally, we established that our client’s research efforts are contributing to the United States’ economy since neurological diseases represent a major financial burden, and improved treatments serve to lessen that burden.
Besides careful descriptions of our client’s research projects, we also included information on her 9 publications that had gathered 107 citations. Moreover, we encouraged her to reach out to experts in her field to gather recommendation letters. Six expert biochemists agreed to lend their support, one of whom wrote, “I fear that without [Client’s] continued work in the United States, progress toward new treatment methods for strokes and other neurological conditions will be slowed, causing an unnecessary delay in the development of life saving drug therapies.”
Because our legal team successfully convinced the USCIS that our client’s research has many benefits for the United States, her I-140 was approved less than two months after we filed the case. We join our client in celebrating this milestone.